HKD 5.05
(0.2%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -22.09 Million CNY | 96.79% |
2022 | -689.05 Million CNY | 31.84% |
2021 | -1.01 Billion CNY | -73.76% |
2020 | -581.84 Million CNY | -30.16% |
2019 | -447.03 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -104.27 Million HKD | -182.17% |
2024 Q2 | -103.38 Million HKD | 0.15% |
2023 Q3 | 64.25 Million HKD | 140.03% |
2023 FY | -22.09 Million CNY | 96.79% |
2023 Q4 | 129.43 Million HKD | 101.45% |
2023 Q2 | -160.48 Million HKD | -97.88% |
2023 Q1 | -81.1 Million HKD | 79.04% |
2022 FY | -689.05 Million CNY | 31.84% |
2022 Q2 | -415.73 Million HKD | 0.0% |
2022 Q4 | -386.85 Million HKD | 0.0% |
2021 FY | -1.01 Billion CNY | -73.76% |
2021 Q2 | -614.3 Million HKD | 0.0% |
2020 FY | -581.84 Million CNY | -30.16% |
2019 FY | -447.03 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 131.176% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 228.093% |